Teva Pharmaceutical Industries | TEVA - Sales Revenues


Teva Pharmaceutical Industries reported $14.63B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Aspen Pharmacare ZAR 21.4B 557M Jun/2025
Cipla INR 75.18B 710M Dec/2025
Dr.Reddys Laboratories INR 87.27B 780M Dec/2025
Guangzhou Baiy CNY 19.77B 410M Sep/2025
Jiangsu Hengrui CNY 7.43B 1.17B Sep/2025
Kalbe Farma IDR 8.91T 675.08B Sep/2025
Richter Gedeon HUF 214.69B 26.79B Sep/2025
Sh Fosun Pharma CNY 9.88B 125.79M Sep/2025
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025